We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Moderna Inc | NASDAQ:MRNA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.23 | -0.18% | 125.36 | 116.45 | 129.00 | 126.3843 | 122.01 | 125.06 | 4,513,134 | 05:00:04 |
1. Name and Address of Reporting Person * Hoge Stephen | 2. Issuer Name and Ticker or Trading Symbol Moderna, Inc. [ MRNA ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) President |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 7/23/2021 | M(1) | 5000 | A | $10.90 | 1614597 | D | |||
Common Stock | 7/23/2021 | M(1) | 10000 | A | $.99 | 1624597 | D | |||
Common Stock | 7/23/2021 | S(1) | 100 | D | $327.96 | 1624497 | D | |||
Common Stock | 7/23/2021 | S(1) | 400 | D | $329.91 (2) | 1624097 | D | |||
Common Stock | 7/23/2021 | S(1) | 5900 | D | $330.96 (3) | 1618197 | D | |||
Common Stock | 7/23/2021 | S(1) | 1333 | D | $332.15 (4) | 1616864 | D | |||
Common Stock | 7/23/2021 | S(1) | 1200 | D | $334.14 (5) | 1615664 | D | |||
Common Stock | 7/23/2021 | S(1) | 800 | D | $335.36 (6) | 1614864 | D | |||
Common Stock | 7/23/2021 | S(1) | 600 | D | $336.81 (7) | 1614264 | D | |||
Common Stock | 7/23/2021 | S(1) | 1333 | D | $338.07 (8) | 1612931 | D | |||
Common Stock | 7/23/2021 | S(1) | 854 | D | $338.90 (9) | 1612077 | D | |||
Common Stock | 7/23/2021 | S(1) | 300 | D | $340.65 (10) | 1611777 | D | |||
Common Stock | 7/23/2021 | S(1) | 297 | D | $341.98 (11) | 1611480 | D | |||
Common Stock | 7/23/2021 | S(1) | 400 | D | $342.76 (12) | 1611080 | D | |||
Common Stock | 7/23/2021 | S(1) | 401 | D | $345.51 (13) | 1610679 | D | |||
Common Stock | 7/23/2021 | S(1) | 400 | D | $346.52 (14) | 1610279 | D | |||
Common Stock | 7/23/2021 | S(1) | 474 | D | $347.83 (15) | 1609805 | D | |||
Common Stock | 7/23/2021 | S(1) | 208 | D | $348.41 (16) | 1609597 | D | |||
Common Stock | 7/26/2021 | M(1) | 5000 | A | $10.90 | 1614597 | D | |||
Common Stock | 7/26/2021 | S(1) | 5000 | D | $351.99 | 1609597 | D | |||
Common Stock | 4116 | I | By Valhalla, LLC | |||||||
Common Stock | 151933 | I (17) | By Trust |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option (Right to Buy) | $10.90 | 7/23/2021 | M (1) | 5000 | (18) | 2/23/2026 | Common Stock | 5000 | $0 | 271972 | D | ||||
Stock Option (Right to Buy) | $.99 | 7/23/2021 | M (1) | 10000 | (19) | 8/19/2023 | Common Stock | 10000 | $0 | 397431 | D | ||||
Stock Option (Right to Buy) | $10.90 | 7/26/2021 | M (1) | 5000 | (18) | 2/23/2026 | Common Stock | 5000 | $0 | 266972 | D |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Hoge Stephen C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE, MA 02139 | President |
Signatures | ||
/s/ Brian Sandstrom, as Attorney-in-Fact | 7/27/2021 | |
**Signature of Reporting Person | Date |
1 Year Moderna Chart |
1 Month Moderna Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions